OCTAGON CAPITAL ADVISORS LP – Celldex Therapeutics, Inc. Transaction History
OCTAGON CAPITAL ADVISORS LP portfolio value:
$21.40M
portfolio value
OCTAGON CAPITAL ADVISORS LP quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 876K | $28.11 | 761.39K | |
| Q2 2022 | share | 0.00% | 0 shares | -5.40M | $26.96 | 761.39K | |
| Q1 2022 | share | 0.00% | 0 shares | -3.48M | $34.06 | 761.39K | |
| Q4 2021 | share | 0.00% | 0 shares | -11.68M | $38.9 | 761.39K | |
| Q3 2021 | share | Increase | +35.63% | 200K shares | 22.33M | $53.99 | 761.39K |
| Q2 2021 | share | 0.00% | 0 shares | 7.20M | $33.44 | 561.39K | |
| Q1 2021 | share | Decrease | -46.09% | -480K shares | -6.68M | $20.6 | 561.39K |
| Q4 2020 | share | Increase | 0.00% | 1.04M shares | 18.24M | $17.52 | 1.04M |